1. Wang, Chenfei, Liu, Xiaoyu, Gao, Yawei, Zhang, Yong, Gao, Shaorong. 2018. Reprogramming of H3K9me3-dependent heterochromatin during mammalian embryo development. In Nature cell biology, 20, 620-631. doi:10.1038/s41556-018-0093-4. https://pubmed.ncbi.nlm.nih.gov/29686265/
2. Sun, Xia, Ma, Qiushuang, Cheng, Yahong, Zhang, Mengchen, Qu, Sifeng. 2023. Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance. In Frontiers in genetics, 14, 1108004. doi:10.3389/fgene.2023.1108004. https://pubmed.ncbi.nlm.nih.gov/36968583/
3. Li, Xiaoqin, Xiong, Fen, Hu, Zhangmin, Xiao, Yichuan, Wang, Deqiang. 2024. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer. In Journal of translational medicine, 22, 90. doi:10.1186/s12967-024-04859-8. https://pubmed.ncbi.nlm.nih.gov/38254099/
4. Yan, Wei, Shi, Xue, Wang, Huihan, Liao, Aijun, Yang, Wei. 2022. Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma. In Journal of translational medicine, 20, 296. doi:10.1186/s12967-022-03476-7. https://pubmed.ncbi.nlm.nih.gov/35773729/
5. Zheng, Lixin, Liang, Xiuming, Li, Shuyan, Chen, Chunyan, Jia, Jihui. 2018. CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression. In EBioMedicine, 38, 69-78. doi:10.1016/j.ebiom.2018.11.009. https://pubmed.ncbi.nlm.nih.gov/30449701/
智鼠故事 
